Advertisement

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Investigating the dangers of unlicensed stem cell clinics

Clinics marketing unlicensed and potentially dangerous stem cell treatments to patients are prevalent in both the US and Canada, according to a series of studies by Dr Leigh Turner from the University of Minnesota’s Center for Bioethics. Turner discusses how these unlicensed clinics operate, the risks they pose to patients and the reputational damage they could inflict on legitimate stem cell research in the pharma sector.

Close
Close
Close

Go Top